ApexPlatform
ApexPlatform Raises $75M Series C to Transform Biotech
Quick Facts
ApexPlatform Raises $75M Series C in Latest Funding Round
ApexPlatform has successfully closed a $75M Series C funding round, marking a significant milestone in the company's growth trajectory. The round was led by Tiger Global, with participation from Bessemer Venture Partners.
Company Overview
Founded in 2023 and headquartered in Los Angeles, CA, ApexPlatform has established itself in the Biotech space. Leading machine learning platform automating enterprise workflows with advanced AI models
With a current valuation of $2B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $75M Series C
- Valuation: $2B
- Lead Investor: Tiger Global
Future Outlook
As ApexPlatform moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
PrimeNet Raises $300M Series C to Transform Biotech
PrimeNet has secured $300M Series C in funding to accelerate growth and innovation. Leading machine learning platform automating enterprise workflows with advanced AI models...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...